AI assistant
Brainsway Ltd. — Director's Dealing 2026
May 26, 2026
6701_rns_2026-05-26_453de857-bd44-45b8-8470-7166270ee630.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
| OMB Number: | 3235-0287 |
|---|---|
| Estimated average burden hours per response | 0.5 |
| 1. Name and Address of Reporting Person Mitrany Rayten Michal Ety | 2. Issuer Name and Ticker or Trading Symbol Brainsway Ltd. [BWAY] 2a. Foreign Trading Symbol |
| --- | --- |
| (Last) | (First) (Middle) |
| 16 HARTUM STREET, RAD TOWER, 14TH FLOOR HAR HAHOTZVIM | |
| (Street) | |
| JERUSALEM | 9777516 |
| (City) | (State) (Zip/Postal Code) |
| ISRAEL | |
| (Country) | |
| Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |
| --- | --- |
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) |
| Ordinary Shares(1) | |
| Ordinary Shares(1) | |
| Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |
| --- | --- |
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security |
Explanation of Responses:
1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
2. The sale price was NIS 45.5588 per share.
3. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.
4. The sale price was NIS 44.7516 per share.
/x/ Ety Mitrany
** Signature of Reporting Person
05/26/2026
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78f(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.